|
× |
 |
The Vasopressin V1b Receptor Antagonist SSR149415 in the Treatment of Major Depressive and Generalized Anxiety Disorders: Results From 4 Randomized, Double-Blind, Placebo-Controlled Studies PDF |
$40.00 |
|
$40.00 |
|
× |
|
Neurological and Psychiatric Manifestations of Cerebral Arteriovenous Malformation: A Case of Hemichorea and Depression PDF |
$40.00 |
|
$40.00 |
|
× |
|
Health-Related Quality-of-Life Measure Enhances Acute Treatment Response Prediction in Depressed Inpatients PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Dual Advantage of Allopurinol in a Patient With Severe Mania and Gout PDF |
$40.00 |
|
$40.00 |
|
|
